Addex Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Addex Therapeutics has a total shareholder equity of CHF1.1M and total debt of CHF0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CHF4.6M and CHF3.5M respectively.
Key information
0%
Debt to equity ratio
CHF0
Debt
| Interest coverage ratio | n/a |
| Cash | CHF3.87m |
| Equity | CHF1.15m |
| Total liabilities | CHF3.50m |
| Total assets | CHF4.64m |
Recent financial health updates
Here's Why Addex Therapeutics (VTX:ADXN) Must Use Its Cash Wisely
Mar 03
Here's Why Addex Therapeutics (VTX:ADXN) Must Use Its Cash Wisely
May 11Recent updates
Here's Why Addex Therapeutics (VTX:ADXN) Must Use Its Cash Wisely
Mar 03Here's Why Addex Therapeutics (VTX:ADXN) Must Use Its Cash Wisely
May 11Is Addex Therapeutics (VTX:ADXN) In A Good Position To Invest In Growth?
Nov 23Increases to CEO Compensation Might Be Put On Hold For Now at Addex Therapeutics Ltd (VTX:ADXN)
Jun 10Is Addex Therapeutics (VTX:ADXN) In A Good Position To Invest In Growth?
Mar 07What Type Of Returns Would Addex Therapeutics'(VTX:ADXN) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?
Jan 12Financial Position Analysis
Short Term Liabilities: ADXN's short term assets (CHF4.2M) exceed its short term liabilities (CHF2.9M).
Long Term Liabilities: ADXN's short term assets (CHF4.2M) exceed its long term liabilities (CHF603.1K).
Debt to Equity History and Analysis
Debt Level: ADXN is debt free.
Reducing Debt: ADXN has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ADXN has sufficient cash runway for 6 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: ADXN is forecast to have sufficient cash runway for 7 months based on free cash flow estimates, but has since raised additional capital.